Has Mahmood Razavi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,371,080 in general payments to Mahmood Razavi, MD across 713 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mahmood Razavi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mahmood Razavi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mahmood Razavi, MD

Vascular & Interventional Radiology · Orange, CANPI 1851388607

Payments from drug & device makers

What this record shows

This record is dominated by other: $1,737,227 of the $2,371,080 with a category attached, or 73.3%. 54 manufacturers reported payments, led by Walk Vascular, LLC at 35.6% of the total. Reporting peaked in 2021 at $1,797,043 and has fallen 94.4% since, to $101,190 in 2025. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,371,080in general payments, 2019–2025

Across 713 payments — averaging $3325.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Walk Vascular, LLC$845K
Medtronic$611K
Boston Scientific$509K
Merit Medical Systems Inc$63K
Abbott$46K
Philips North America LLC$43K
plus $254K from 48 others

$693,253in research payments, 2019–2025

Across 140 payments — averaging $4951.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Mercator Medsystems, Inc.$337K
Medtronic$151K
Abbott$112K
Bard Peripheral Vascular, Inc.$61K
Boston Scientific$15K
Veniti, Inc.$5K
plus $12K from 6 others

$59,066in ownership & investment interests, 2019–2025

Across 8 payments — averaging $7383.24 each. An ownership or investment interest held by the physician or an immediate family member.

Perfuze Limited$57K
Reflow Medical Inc$2K
Intervene, Inc.$0
Devoro Medical Inc.$0
Walk Vascular, LLC$0

What the payments were for

Consulting fees$376,93816%
Speaking & faculty fees$136,3306%
Travel & lodging$55,9482%
Food & beverage$24,1931%
Ownership interest$40,4432%
Other$1,737,22773%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Walk Vascular, LLC	1	$844,854
Medtronic(3 entities)	123	$611,372
Boston Scientific	148	$509,324
Merit Medical Systems Inc	38	$62,942
Abbott	87	$46,188
Philips North America LLC	37	$42,573
Asahi Intecc USA, Inc.	7	$40,428
Microvention, Inc.	16	$35,296
Cardiovascular Systems Inc.	52	$24,915
Shockwave Medical, Inc	24	$24,138
Reflow Medical Inc	12	$16,401
Sirtex Medical Inc	15	$16,299
Penumbra, Inc.	12	$15,393
Bard Peripheral Vascular, Inc.	8	$11,277
Heraeus Medical Components, LLC	11	$10,500
Angiodynamics, Inc.	7	$8,452
Terumo Medical Corporation	6	$6,950
Surmodics, Inc.	9	$6,422
Vesper Medical	4	$5,300
Biocompatibles UK Ltd	2	$5,217
Edwards Lifesciences	6	$4,003
Cordis US CORP.	4	$3,134
W. L. Gore & Associates, Inc.	9	$3,011
Mercator Medsystems, Inc.	3	$2,567
Daiichi Sankyo Inc.	1	$2,480
Recor Medical Inc	16	$2,105
Cook Incorporated	1	$2,000
Blackswan Vascular, Inc.	2	$1,925
Intact Vascular, Inc.	2	$800
Devoro Medical Inc.	1	$700
Inquis Medical, Inc.	1	$550
Provisio Medical, Inc.	1	$500
Endologix LLC	3	$457
Inspiremd Ltd	2	$408
Cook Medical LLC	5	$284
Johnson & Johnson(2 entities)	7	$277
Imperative Care, Inc	4	$180
Avantec Vascular Corporation	2	$179
Siemens Medical Solutions USA, Inc.	2	$171
Instylla, Inc.	1	$167
Veryan Medical Incorporated	2	$151
Cardiva Medical, Inc.	4	$133
Amplitude Vascular Systems, Inc.	1	$111
Argon Medical Devices, Inc.	1	$94
Balt USA, LLC	1	$85
Silk Road Medical, Inc.	2	$75
Stryker	2	$75
Medical Device Business Services, Inc.	1	$47
Mimedx Group, Inc.	1	$46
Inari Medical, Inc.	1	$39
Nipro Medical Corporation	1	$27
Lemaitre Vascular, Inc.	2	$26
BD	1	$19
E.r. Squibb & Sons, L.L.C.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$438,845
Wrapsody Stent Graft$37,460
GENERAL VASCULAR INTERVENTION$24,015
(9520) IGT Devices Undivided$21,506
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$21,108
ASAHI PTCA Guide Wire$16,628
IN.PACT Admiral$16,547
LAVA LES (Liquid Embolic System)$15,581
Peripheral Orbital Atherectomy System$15,367
Abre$13,606
Indigo$11,766
Omnilink Elite vascular stent system$10,473
Diamondback Peripheral$9,407
Auryon Laser System 100-120 Vac$8,369
SUPERA$7,598
GENERAL - STENTS$7,467
(6554) Peripheral Vascular Undivided$7,402
Stellarex$7,057
Emboshield NAV6 system$7,000
LC BEAD$6,804

How this compares

$2,371,080 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024

$143,435

Medicare patients

378

Services billed

976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	11	$9,840

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Orange

Kevin BurnsOrange$1.1M
Bhavraj KhalsaOrange$407K
Nadine Abi-JaoudehOrange$105K
Keith TerasakiLos Angeles$1.7M
Bart DolmatchMountain View$1.7M
Edward LeeLos Angeles$1.4M
Alexander MisonoNewport Beach$1.3M
Siddharth PadiaLos Angeles$960K
Satoshi TateshimaLos Angeles$764K
Blaise BaxterSan Francisco$757K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →